Literature DB >> 1084767

Insulin binding of acute lymphocytic leukemia cells.

E C Esber, D N Buell, S L Leikin.   

Abstract

Because of differences in insulin binding of cultured lymphoic cell lines, T- and B-cell surface receptor and 125I-insulin binding studies were performed on the bone marrow and peripheral blood leukocytes of 13 children with active acute lymphocytec leukemia. Based on surface receptors, nine patients had null-cell disease and four had T-cell disease. The mean per cent insulin binding of the bone marrow cells from the null-cell patients was 10.0% +/- 8.1 and from the T-cell patients was 0.18% +/- 0.13. The mean insulin binding of the cell suspensions of the peripheral blood from the null-cell patients was 7.3% +/- 7.5 and 0.07% +/- 0.06 from the T-cell patients. Displacement studies with nonradioactive insulin indicated that null leukemic cells bore specific binding sites. These results indicated that there may be metabolic as well as surface membrane heterogeneity among the acute lymphocytic leukemias of childhood.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1084767

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  2 in total

Review 1.  Metformin, an Anti-diabetic Drug to Target Leukemia.

Authors:  Giulia Biondani; Jean-François Peyron
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-10       Impact factor: 5.555

2.  Increased body mass index is a risk factor for acute promyelocytic leukemia.

Authors:  Sarah M Kashanian; Andrew Y Li; Moaath Mustafa Ali; Mark E Sutherland; Vu H Duong; Bryan C Hambley; Kyle Zacholski; Firas El Chaer; Noa G Holtzman; Mohammad Imran; Ciera L Patzke; Jonathan Cornu; Alison Duffy; Amy E Dezern; Ivana Gojo; Kelly J Norsworthy; Mark J Levis; B Douglas Smith; Maria R Baer; Gabriel Ghiaur; Ashkan Emadi
Journal:  EJHaem       Date:  2021-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.